The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2024
Filed:
Feb. 13, 2023
Applicants:
Abbvie Inc., North Chicago, IL (US);
Neurocrine Biosciences, Inc., San Diego, CA (US);
Inventors:
Jayanthy Jayanth, Buffalo Grove, IL (US);
Kevin C. Spence, Vernon Hills, IL (US);
Gregory A. McClelland, San Diego, CA (US);
Anna V. Stepanenko, Del Mar, CA (US);
Tzuchi R. Ju, North Chicago, IL (US);
Xi Shao, Lake Bluff, IL (US);
Assignees:
AbbVie Inc., North Chicago, IL (US);
Neurocrine Biosciences, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/513 (2006.01); A61K 9/20 (2006.01); A61P 5/30 (2006.01); A61P 15/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2059 (2013.01); A61P 5/30 (2018.01); A61P 15/00 (2018.01);
Abstract
The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.